Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 2
2011 3
2012 4
2013 4
2014 3
2015 2
2016 2
2017 1
2018 3
2019 6
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Results by year
Filters applied: . Clear all
Page 1
Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations.
Prentoe J, Velázquez-Moctezuma R, Augestad EH, Galli A, Wang R, Law M, Alter H, Bukh J. Prentoe J, et al. Proc Natl Acad Sci U S A. 2019 May 14;116(20):10039-10047. doi: 10.1073/pnas.1822002116. Epub 2019 Apr 30. Proc Natl Acad Sci U S A. 2019. PMID: 31040211 Free PMC article.
Genetic and structural insights into broad neutralization of hepatitis C virus by human VH1-69 antibodies.
Tzarum N, Giang E, Kong L, He L, Prentoe J, Augestad E, Hua Y, Castillo S, Lauer GM, Bukh J, Zhu J, Wilson IA, Law M. Tzarum N, et al. Among authors: prentoe j. Sci Adv. 2019 Jan 2;5(1):eaav1882. doi: 10.1126/sciadv.aav1882. eCollection 2019 Jan. Sci Adv. 2019. PMID: 30613781 Free PMC article.
Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design.
Keck ZY, Pierce BG, Lau P, Lu J, Wang Y, Underwood A, Bull RA, Prentoe J, Velázquez-Moctezuma R, Walker MR, Luciani F, Guest JD, Fauvelle C, Baumert TF, Bukh J, Lloyd AR, Foung SKH. Keck ZY, et al. Among authors: prentoe j. PLoS Pathog. 2019 May 17;15(5):e1007772. doi: 10.1371/journal.ppat.1007772. eCollection 2019 May. PLoS Pathog. 2019. PMID: 31100098 Free PMC article.
Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms.
Velázquez-Moctezuma R, Galli A, Law M, Bukh J, Prentoe J. Velázquez-Moctezuma R, et al. Among authors: prentoe j. J Virol. 2019 Feb 5;93(4):e01909-18. doi: 10.1128/JVI.01909-18. Print 2019 Feb 15. J Virol. 2019. PMID: 30487284 Free PMC article.
In Vitro Neutralization Assay Using Cultured Hepatitis C Virus.
Prentoe J, Bukh J. Prentoe J, et al. Methods Mol Biol. 2019;1911:433-439. doi: 10.1007/978-1-4939-8976-8_29. Methods Mol Biol. 2019. PMID: 30593643
Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.
Riva L, Song OR, Prentoe J, Helle F, L'homme L, Gattolliat CH, Vandeputte A, Fénéant L, Belouzard S, Baumert TF, Asselah T, Bukh J, Brodin P, Cocquerel L, Rouillé Y, Dubuisson J. Riva L, et al. Among authors: prentoe j. J Virol. 2018 Apr 27;92(10):e01982-17. doi: 10.1128/JVI.01982-17. Print 2018 May 15. J Virol. 2018. PMID: 29491159 Free PMC article.
High density Huh7.5 cell hollow fiber bioreactor culture for high-yield production of hepatitis C virus and studies of antivirals.
Pihl AF, Offersgaard AF, Mathiesen CK, Prentoe J, Fahnøe U, Krarup H, Bukh J, Gottwein JM. Pihl AF, et al. Among authors: prentoe j. Sci Rep. 2018 Nov 30;8(1):17505. doi: 10.1038/s41598-018-35010-5. Sci Rep. 2018. PMID: 30504788 Free PMC article.
Hepatitis C Virus-Escape Studies for Human Monoclonal Antibody AR4A Reveal Isolate-Specific Resistance and a High Barrier to Resistance.
Velázquez-Moctezuma R, Galli A, Law M, Bukh J, Prentoe J. Velázquez-Moctezuma R, et al. Among authors: prentoe j. J Infect Dis. 2019 Jan 1;219(1):68-79. doi: 10.1093/infdis/jiy481. J Infect Dis. 2019. PMID: 30102355 Free PMC article.
HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice.
Prentoe J, Verhoye L, Velázquez Moctezuma R, Buysschaert C, Farhoudi A, Wang R, Alter H, Meuleman P, Bukh J. Prentoe J, et al. Gut. 2016 Dec;65(12):1988-1997. doi: 10.1136/gutjnl-2015-310300. Epub 2015 Nov 20. Gut. 2016. PMID: 26589670 Free PMC article.
29 results
Jump to page